Custom Health Files Preliminary Short Form Base Shelf Prospectus and Refiles Certain Continuous Disclosure Documents
Groupon Announces Date for Third Quarter 2026 Financial Results
Terraces Menswear Launches Built for the Game Ahead Autumn Winter 2026 Campaign
BrandPilot AI Announces Paid Trial with B2C Dermatology and Medical Aesthetics Brand
AmeriTrust Announces Change of Auditor
VANCOUVER, British Columbia–(BUSINESS WIRE)–Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) today announced production and…
ATLANTA & NEW YORK–(BUSINESS WIRE)–Intercontinental Exchange (NYSE: ICE), a leading global provider of data, technology…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research that details its approach to environmental, social, and governance (ESG)…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its First-Quarter 2022 U.S. Bank Compendium. The Compendium provides our latest…
SEATTLE, May 12, 2022 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused…
– FTX-6058 is the only oral hemoglobin F (HbF) inducer in clinical development -Data will…
Phase 1 Multiple-Ascending Dose Data for CRN04894 Expected in 2Q22 Paltusotine’s Phase 3 PATHFNDR Trials…
◦ UCART20x22 preclinical data presented at AACR demonstrated PoC with robust in vitro and in vivo…
SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or…
Initial data from pivotal FIREFLY-1 study with tovorafenib (DAY101) in relapsed pediatric low-grade glioma (pLGG)…
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a…
Positive top-line results from registration-enabling study of cosibelimab in metastatic cutaneous squamous cell carcinoma announced…
Company on track to dose first transfusion-dependent beta thalassemia patient with EDIT-301 by year-end CAMBRIDGE, Mass.,…
AUSTIN, Texas, May 12, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
– Peer-reviewed publication highlights 22 new oncogenic HER2 driver mutations identified and experimentally validated with…
Montrouge, France, May 12, 2022 DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary…
Internet City, Dubai–(Newsfile Corp. – May 12, 2022) – LBank Exchange, a global digital asset…
Internet City, Dubai–(Newsfile Corp. – May 12, 2022) – LBank Exchange, a global digital asset…
The phase 3 ASCERTAIN – AML clinical study of decitabine and cedazuridine, administered orally as…
BURLINGTON, Vt.–(BUSINESS WIRE)–Teucrium Trading, LLC, the Sponsor of agricultural futures-based ETFs, today announced that its…